Amanote Research

Amanote Research

    RegisterSign In

Puk26 - Impact of Emerging Hif-Ph Inhibitors on Renal Anemia Treatment

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2824
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

October 1, 2018

Authors
J. KhanT. BlackstockY. PrivolnevR. Moore
Publisher

Elsevier BV


Related search

Effects of Histone Deacetylase Inhibitors on HIF-1

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2006English

New and Emerging HDAC Inhibitors for Cancer Treatment

Journal of Clinical Investigation
Medicine
2014English

Emerging Drugs for Sickle Cell Anemia

Expert Opinion on Emerging Drugs
Pharmacology
2014English

M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2011English

The Emerging Science of Body Weight Regulation and Its Impact on Obesity Treatment

Journal of Clinical Investigation
Medicine
2003English

Berries: Emerging Impact on Cardiovascular Health

Nutrition Reviews
MedicineNutritionDietetics
2010English

Differential Effects of HIF-α Isoforms on Apoptosis in Renal Carcinoma Cell Lines

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

Role of Erythropoietin in Renal Anemia Therapy

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

Treatment of Aplastic Anemia

Oncologist
Cancer ResearchMedicineOncology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy